Fresenius Medical Care Ukraine opens hemodialysis center in Kharkiv

KYIV. Oct 18 (Interfax-Ukraine) – The official representative of Germany’s Fresenius Medical Care – Fresenius Medical Care Ukraine LLC – has opened a hemodialysis center in Kharkiv, which provides hemodialysis services to patients with renal failure under the Medical Guarantee Program.

According to the company’s press release, Kharkiv has become the third city in Ukraine where Fresenius hemodialysis centers operate.

The medical center plans to equip 30 Fresenius 5008S hemodialysis machines, a water treatment system and equipment for automatic mixing of solutions.

More than 165 patients with chronic kidney disease will be able to receive hemodialysis services at the center.

The center provides patients with hemodialysis treatment on an outpatient basis, as well as provides specialist advice (general practitioner and nephrologist) and qualified outpatient care.

In addition, the dialysis center has its own water treatment system and a system for creating concentrates, which are necessary for dialysis. The quality of the dialysis of each patient is monitored by both the medical staff of the center and the special program EuClid, which collects and analyzes patient data.

The company emphasizes that Fresenius Medical Care Ukraine is one of the private medical institutions that fully complies with the requirements of the National Health Service of Ukraine, has entered into an agreement with it and can provide extracorporeal hemodialysis services at the rate established at the state level. These services are free of charge for patients.

As reported, since 2009, Fresenius Medical Care Ukraine hemodialysis centers have been operating in Cherkasy and Chernihiv.

Currently, almost 12,000 people in Ukraine do not have kidney function, these patients need renal replacement therapy: dialysis or kidney transplantation.

Another 25,000 people are approaching the final stage of chronic kidney disease.

Fresenius Medical Care was founded in Bad Homburg (Germany) in 1912. It operates in 150 countries around the world and is a global market leader in products and services for people with kidney failure. It constantly provides dialysis treatment to 346,500 patients in more than 4,000 clinics around the world.